We are seeking participants for a paid clinical study. (No medical insurance needed)

See enrolling studies
Now enrolling · Phase I–IV

Advancing Research, Improving Lives

PRIME Trials conducts Phase I–IV clinical trials across multiple therapeutic areas. Your participation helps bring safer, more effective treatments to everyone.

A clinical research participant
Research and care

Why Prime

Because patient safety and data integrity come first.

We balance the exacting precision of Phase I–IV trials with genuine, empathetic care — so participating feels safe, understood, and meaningful.

Safety first

Every trial follows strict FDA and IRB protocols. Your wellbeing is monitored at every visit.

Cutting-edge science

We partner with leading pharmaceutical and device companies on the newest therapies.

Human-centric care

Dedicated coordinators guide you through every step — no medical jargon, just support.

Flexible visits

Evening and weekend appointments across three sites, with compensated participation.

Therapeutic Areas

Research across the conditions that matter most

Explore our active therapeutic areas. Select one to see the trials currently enrolling.

Now Enrolling

Active studies seeking participants

View all studies
Ophthalmology Recruiting

One-Time Injection for Geographic Atrophy Due to Dry AMD of the Eye

Evaluating the efficacy, safety, and tolerability of an investigational one-time gene therapy given as a single injection under the retina in adults with geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). Participants are randomly assigned to receive the investigational therapy or to be followed without treatment, with regular eye exams and imaging over 12 months. Participants in the untreated group may be offered the chance to receive the therapy after the study ends. Participation is voluntary. Transportation to and from study visits is always provided.

Phase III· 12 months, with optional long-term follow-up· Up to $1,200, plus transportation provided
Enroll now
Pediatric and Family Recruiting

Type 1 Diabetes Research Study (Children & Teens Under 18)

Help advance type 1 diabetes research. Children and teens under 18 are invited to take part in a blood sample collection study at our Houston, TX site. Participation is voluntary, and we pay for your Uber to and from the visit. Compensation for gas and time: up to $150. To learn more, text “INFO” to (281) 220-9306.

Specimen Collection· Single visit· Up to $150 for gas and time
Enroll now
Pediatric and Family Recruiting

Pediatric Blood Specimen Collection (Ages 2–5)

Healthy boys and girls, ages 2–5 years old, are needed for blood specimen collections. Choosing to donate is optional. A patient stipend is provided. Donating blood or other samples for research may help find a cure or preventive measure for various diseases and conditions, and lead to improved methods of diagnosis and treatment. Participating in research is a simple way of playing an active role in your own health while also helping others.

Specimen Collection· Single visit· Patient stipend provided
Enroll now

Our Team

Led by physicians who care

Meet the team

Ophthalmology

Jaafar Fadl El-Annan, M.D., M.D.

Principal Investigator

Board-certified ophthalmologist and fellowship-trained vitreoretinal surgeon with extensive experience in medical and surgical retina, academic ophthalmology, translational research, and clinical investigation. President of Annan Retina Eye Center and Clinical Associate Professor at Baylor College of Medicine, The University of Texas Medical Branch, and MD Anderson Cancer Center.

Cardiology

Alexander Butkevich, MD

Principal Investigator

Dr. Alexander Butkevich is a board-certified cardiologist specializing in cardiovascular disease and advanced heart failure and transplant cardiology. He brings nearly two decades of private-practice experience in general cardiology, cardiac transplantation, mechanical circulatory support, and the management of complex cardiovascular conditions. His research experience spans Phase II and Phase III studies involving heart failure, myocardial infarction, coronary artery disease, atrial fibrillation, hypertension, dyslipidemia, and transthyretin amyloid cardiomyopathy.

Psychiatry

Wafaa Farag, MD

Principal Investigator

Dr. Wafaa Farag is a board-certified psychiatrist with more than 25 years of experience treating children, adolescents, and adults in outpatient, inpatient, and emergency settings. Her clinical research experience includes Phase II and Phase III studies in major depressive disorder, bipolar disorder, schizophrenia, post-traumatic stress disorder, generalized anxiety disorder, ADHD, and insomnia. At Prime Research Institute, she provides medical oversight, ensures protocol adherence, and supports the safe and ethical participation of research subjects.

Our Locations

Find a site near you

All locations
PRIME Trials — Pearland (Smith Ranch)

PRIME Trials — Pearland (Smith Ranch)

2743 Smith Ranch Rd, Ste 1001, Pearland, TX 77584

A PRIME Trials clinical site offering Phase I–IV trials across our therapeutic areas.

Free on-site parking available.

Accessible by car and local transit.

Mon–Fri 7am–7pm · Sat 8am–2pm Call this site
PRIME Trials — Houston

PRIME Trials — Houston

2020 Southwest Fwy, #205, Houston, TX 77098

A PRIME Trials clinical site offering Phase I–IV trials across our therapeutic areas.

Free on-site parking available.

Accessible by car and local transit.

Mon–Fri 7am–6pm Call this site
PRIME Trials — Pearland (Shadow Creek)

PRIME Trials — Pearland (Shadow Creek)

12234 Shadow Creek Pkwy, #6106, Pearland, TX 77584

A PRIME Trials clinical site offering Phase I–IV trials across our therapeutic areas.

Free on-site parking available.

Accessible by car and local transit.

Mon–Sat 7am–7pm Call this site

Be part of the next breakthrough.

Join our database and we will notify you when a study matches your profile — or browse active trials today.